Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBOLD: Phenotype Predictors of Cognitive Outcomes in Geriatric Depression
NCT05273996Phase 4Active, not recruiting
- Start
- Sep 2021
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sertraline, bupropion, desvenlafaxine in major depressive disorder (MDD). Started Sep 2021; status: active, not recruiting.
02
Drugs
sertralinebupropiondesvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05273996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05273996.